Rankings
The financial health league table
426 large listed companies ranked by their score out of 100, from their latest annual report. Filter by country and sector.
| # | Company | Score | Op. margin | Growth | ROE | Debt / equity | FCF margin | Revenue | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | INTUITIVE SURGICAL INCISRG | 95 | 29.3% | +20.5% | 16.7% | – | 24.7% | $10.1B | |
| 2 | IDEXX LABORATORIES INC /DEIDXX | 93 | 31.6% | +10.4% | 66.2% | 0.28× | 24.6% | $4.3B | |
| 3 | VERTEX PHARMACEUTICALS INC / MAVRTX | 86 | 34.8% | +8.9% | 22.5% | – | 26.6% | $12.0B | |
| 4 | NOVARTIS AGNVS | 85 | 32.4% | +8.4% | 31.0% | 0.64× | 32.3% | $54.5B | |
| 5 | NOVO NORDISK A SNVO | 84 | 41.3% | +6.4% | 60.7% | 0.67× | 19.1% | kr 309.1B | |
| 6 | STRYKER CORPSYK | 83 | 19.5% | +11.2% | 15.1% | 0.71× | 17.1% | $25.1B | |
| 7 | BOSTON SCIENTIFIC CORPBSX | 82 | 18.0% | +19.9% | 12.6% | 0.47× | 18.2% | $20.1B | |
| 8 | Edwards Lifesciences CorpEW | 82 | 20.8% | +11.5% | 10.6% | 0.06× | 22.0% | $6.1B | |
| 9 | Merck & Co., Inc.MRK | 80 | – | +1.3% | 36.9% | 0.94× | 19.0% | $65.0B | |
| 10 | ELI LILLY & CoLLY | 80 | – | +44.7% | 101.2% | 1.60× | 25.8% | $65.2B | |
The other 29 companies are included in the Investor plan. Try free for 7 days → | |||||||||